JENNIFER DODGE: Open Payments
NPI 1558402230 · MOUNT KISCO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,579 in 70 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $382 · 2025 $1,579
Food & beverage: $1,495Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $421 |
| Janssen Biotech, Inc. | 6 | $219 |
| Madrigal Pharmaceuticals | 8 | $212 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $191 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $174 |
| QOL Medical, LLC | 3 | $115 |
| Aimmune Therapeutics, Inc. | 3 | $62 |
| GENZYME CORPORATION | 2 | $52 |
| Ardelyx, Inc. | 2 | $40 |
| EVOKE PHARMA, INC. | 2 | $34 |
Products named: TREMFYA, REZDIFFRA, ENTYVIO, SKYRIZI, XIFAXAN, Sucraid, RINVOQ, CREON.
Industry payments across NY — which companies pay providers there.
